4.5 Article

Semi-synthetic aristolactams-inhibitors of CDK2 enzyme

期刊

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
卷 20, 期 4, 页码 1384-1387

出版社

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bmcl.2010.01.007

关键词

Semi-synthetic analogs; Aristolactams; IC(50); SAR

向作者/读者索取更多资源

Several analogs of aristolochic acids were isolated and derivatized into their lactam derivatives to study their inhibition in CDK2 assay. The study helped to derive some conclusions about the structure-activity relation around the phenanthrin moiety. Semi-synthetic aristolactam 21 showed good activity with inhibition IC(50) of 35 nM in CDK2 assay. The activity of this compound was comparable to some of the most potent synthetic compounds reported in the literature. (C) 2010 Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Multidisciplinary Sciences

Selective small-molecule inhibition of an RNA structural element

John A. Howe, Hao Wang, Thierry O. Fischmann, Carl J. Balibar, Li Xiao, Andrew M. Galgoci, Juliana C. Malinverni, Todd Mayhood, Artjohn Villafania, Ali Nahvi, Nicholas Murgolo, Christopher M. Barbieri, Paul A. Mann, Donna Carr, Ellen Xia, Paul Zuck, Dan Riley, Ronald E. Painter, Scott S. Walker, Brad Sherborne, Reynalda de Jesus, Weidong Pan, Michael A. Plotkin, Jin Wu, Diane Rindgen, John Cummings, Charles G. Garlisi, Rumin Zhang, Payal R. Sheth, Charles J. Gill, Haifeng Tang, Terry Roemer

NATURE (2015)

Article Biochemistry & Molecular Biology

Crystal Structures of MEK1 Binary and Ternary Complexes with Nucleotides and Inhibitors

Thierry O. Fischmann, Catherine K. Smith, Todd W. Mayhood, Joseph E. Myers, Paul Reichert, Anthony Mannarino, Donna Carr, Hugh Zhu, Jesse Wong, Rong-Sheng Yang, Hung V. Le, Vincent S. Madison

BIOCHEMISTRY (2009)

Article Chemistry, Medicinal

Design, synthesis and SAR of thienopyridines as potent CHK1 inhibitors

Lianyun Zhao, Yingxin Zhang, Chaoyang Dai, Timothy Guzi, Derek Wiswell, Wolfgang Seghezzi, David Parry, Thierry Fischmann, M. Arshad Siddiqui

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)

Article Chemistry, Medicinal

Discovery of pyrazolo[1,5-a]pyrimidine-based CHK1 inhibitors: A template-based approach-Part 1

Michael P. Dwyer, Kamil Paruch, Marc Labroli, Carmen Alvarez, Kerry M. Keertikar, Cory Poker, Randall Rossman, Thierry O. Fischmann, Jose S. Duca, Vincent Madison, David Parry, Nicole Davis, Wolfgang Seghezzi, Derek Wiswell, Timothy J. Guzi

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)

Article Chemistry, Medicinal

Discovery of pyrazolo[1,5-a]pyrimidine-based CHK1 inhibitors: A template-based approach-Part 2

Marc Labroli, Kamil Paruch, Michael P. Dwyer, Carmen Alvarez, Kartik Keertikar, Cory Poker, Randall Rossman, Jose S. Duca, Thierry O. Fischmann, Vincent Madison, David Parry, Nicole Davis, Wolfgang Seghezzi, Derek Wiswell, Timothy J. Guzi

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2011)

Article Chemistry, Medicinal

Potency switch between CHK1 and MK2: Discovery of imidazo[1,2-a]pyrazine- and imidazo[1,2-c]pyrimidine-based kinase inhibitors

Zhaoyang Meng, Jeffrey P. Ciavarri, Andrew McRiner, Yinyan Zhao, Lianyun Zhao, Panduranga Adulla Reddy, Xingmin Zhang, Thierry O. Fischmann, Charles Whitehurst, M. Arshad Siddiqui

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)

Article Chemistry, Medicinal

Structure-based design and optimization of 2-aminothiazole-4-carboxamide as a new class of CHK1 inhibitors

Xiaohua Huang, Cliff C. Cheng, Thierry O. Fischmann, Jose S. Duca, Matthew Richards, Praveen K. Tadikonda, Panduranga Adulla Reddy, Lianyun Zhao, M. Arshad Siddiqui, David Parry, Nicole Davis, Wolfgang Seghezzi, Derek Wiswell, Gerald W. Shipps

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2013)

Article Biochemistry & Molecular Biology

Structure-guided discovery of cyclin-dependent kinase inhibitors

Thierry O. Fischmann, Alan Hruza, Jose S. Duca, Lata Ramanathan, Todd Mayhood, William T. Windsor, Hung V. Le, Thimothy J. Guzi, Michael P. Dwyer, Kamil Paruch, Ronald J. Doll, Emma Lees, David Parry, Wolfgang Seghezzi, Vincent Madison

BIOPOLYMERS (2008)

Article Biochemistry & Molecular Biology

Structural basis of CX-4945 binding to human protein kinase CK2

Andrew D. Ferguson, Payal R. Sheth, Andrea D. Basso, Sunil Paliwal, Kimberly Gray, Thierry O. Fischmann, Hung V. Le

FEBS LETTERS (2011)

Article Instruments & Instrumentation

Key steps in the structure-based optimization of the hepatitis C virus NS3/4A protease inhibitor SCH503034

Vincent Madison, Andrew J. Prongay, Zhuyan Guo, Nanhua Yao, John Pichardo, Thierry Fischmann, Corey Strickland, Joseph Myers, Patricia C. Weber, Brian M. Beyer, Richard Ingram, Zhi Hong, Winifred W. Prosise, Lata Ramanathan, S. Shane Taremi, Taisa Yarosh-Tomaine, Rumin Zhang, Mary Senior, Rong-Sheng Yang, Bruce Malcolm, Ashok Arasappan, Frank Bennett, Stephane L. Bogen, Kevin Chen, Edwin Jao, Yi-Tsung Liu, Raymond G. Lovey, Anil K. Saksena, Srikanth Venkatraman, Viyyoor Girijavallabhan, F. George Njoroge

JOURNAL OF SYNCHROTRON RADIATION (2008)

Article Chemistry, Medicinal

Discovery of Dinaciclib (SCH 727965): A Potent and Selective Inhibitor of Cyclin-Dependent Kinases

Kamil Paruch, Michael P. Dwyer, Carmen Alvarez, Courtney Brown, Tin-Yau Chan, Ronald J. Doll, Kerry Keertikar, Chad Knutson, Brian McKittrick, Jocelyn Rivera, Randall Rossman, Greg Tucker, Thierry Fischmann, Alan Hruza, Vincent Madison, Amin A. Nomeir, Yaolin Wang, Paul Kirschmeier, Emma Lees, David Parry, Nicole Sgambellone, Wolfgang Seghezzi, Lesley Schultz, Frances Shanahan, Derek Wiswell, Xiaoying Xu, Quiao Zhou, Ray A. James, Vidyadhar M. Paradkar, Haengsoon Park, Laura R. Rokosz, Tara M. Stauffer, Timothy J. Guzi

ACS MEDICINAL CHEMISTRY LETTERS (2010)

Article Chemistry, Medicinal

Discovery of a Novel Series of CHK1 Kinase Inhibitors with a Distinctive Hinge Binding Mode

Xiaohua Huang, Cliff C. Cheng, Thierry O. Fischmann, Jose S. Duca, Xianshu Yang, Matthew Richards, Gerald W. Shipps

ACS MEDICINAL CHEMISTRY LETTERS (2012)

Article Immunology

Characterization and Modeling of Reversible Antibody Self-Association Provide Insights into Behavior, Prediction, and Correction

Carl Mieczkowski, Alan Cheng, Thierry Fischmann, Mark Hsieh, Jeanne Baker, Makiko Uchida, Gopalan Raghunathan, Corey Strickland, Laurence Fayadat-Dilman

Summary: Research has shown that self-association of antibodies can be modulated through single point mutations, affecting both self-interaction and target binding. Different experimental methods can be used to assess and validate antibody self-interaction, aiding in the correction of self-association issues.

ANTIBODIES (2021)

Article Chemistry, Medicinal

Versatile templates for the development of novel kinase inhibitors: Discovery of novel CDK inhibitors

Michael P. Dwyer, Kamil Paruch, Carmen Alvarez, Ronald J. Doll, Kerry Keertikar, Jose Duca, Thierry O. Fischmann, Alan Hruza, Vincent Madison, Emma Lees, David Parry, Wolfgang Seghezzi, Nicole Sgambellone, Frances Shanahan, Derek Wiswell, Timothy J. Guzi

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2007)

Article Chemistry, Medicinal

Design and synthesis of a library of C2-substituted sulfamidoadenosines to probe bacterial permeability

Shibin Zhao, Julian Maceren, Mia Chung, Samantha Stone, Raphael Geiben, Melissa L. Boby, Bradley S. Sherborne, Derek S. Tan

Summary: Antibiotic resistance is a major threat to public health, with Gram-negative bacteria presenting unique challenges due to their low permeability and efflux pumps. Limited understanding of the chemical rules for overcoming these barriers hinders antibacterial drug discovery. Efforts to address this issue, such as screening compound libraries and using cheminformatic analysis, have led to the design of sulfamidoadenosines with diverse substituents, showing potential utility in accumulation in Escherichia coli.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2024)

Article Chemistry, Medicinal

Design of MERS-CoV entry inhibitory short peptides based on helix-stabilizing strategies

Jichun Li, Qing Li, Shuai Xia, Jiahuang Tu, Longbo Zheng, Qian Wang, Shibo Jiang, Chao Wang

Summary: This study successfully developed a short peptide mimetic as a MERS-CoV fusion inhibitor by reproducing the key recognition features of the HR2 helix. The resulting 23-mer lipopeptide showed comparable inhibitory effect to the 36-mer HR2 peptide HR2P-M2. This has important implications for developing short peptide-based antiviral agents to treat MERS-CoV infection.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2024)

Article Chemistry, Medicinal

Development of novel β2-adrenergic receptor agonists for the stimulation of glucose uptake - The importance of chirality and ring size of cyclic amines

Krista Jaunsleine, Linda Supe, Jana Spura, Sten van Beek, Anna Sandstrom, Jessica Olsen, Carina Halleskog, Tore Bengtsson, Ilga Mutule, Benjamin Pelcman

Summary: Beta(2)-adrenergic receptor agonists can stimulate glucose uptake by skeletal muscle cells and are therefore potential treatments for type 2 diabetes. The chirality of compounds has a significant impact on the activity of these agonists. This study found that certain synthesized compounds showed higher glucose uptake activity. These findings provide important information for the design of novel beta(2)AR agonists for T2D treatment.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2024)

Article Chemistry, Medicinal

Conformationally constrained potent inhibitors for enhancer of zeste homolog 2 (EZH2)

Xin Xu, Jia Chen, Guan Wang, Xiaojuan Zhang, Qiang Li, Xiaobo Zhou, Fengying Guo, Min Li

Summary: The study focuses on EZH2, a promising therapeutic target for various types of cancers. Researchers designed and synthesized a series of novel derivatives aiming to enhance the EZH2 inhibition activity. Among them, compound 28 displayed potent EZH2 inhibition activity and showed high anti-proliferative effects in lymphoma cell lines and xenograft mouse models. The study suggests that compound 28 has potential as a therapeutic candidate for EZH2-associated cancers.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2024)

Article Chemistry, Medicinal

The potential of Rhein's aromatic amines for Parkinson's disease prevention and treatment: α-Synuclein aggregation inhibition and disaggregation of preformed fibers

Wei Zhang, Wei Liu, Ya-Dong Zhao, Li-Zi Xing, Ji Xu, Rui-Jun Li, Yun-Xiao Zhang

Summary: This study developed a series of aromatic amide derivatives based on Rhein and investigated their inhibitory activity against alpha-Syn aggregation. Two of these compounds showed promising potential in treating Parkinson's disease by stabilizing alpha-Syn's conformation and disassembling alpha-Syn oligomers and fibrils.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2024)

Article Chemistry, Medicinal

Design, synthesis and biological evaluation of novel cationic liposomes loaded with melphalan for the treatment of cancer

Mani Sharma, S. S. S. S. Sudha Ambadipudi, Neeraj Kumar Chouhan, V. Lakshma Nayak, Srihari Pabbaraja, Sai Balaji Andugulapati, Ramakrishna Sistla

Summary: Therapeutically active lipids in drug delivery systems can enhance the safety and efficacy of treatment. The liposome formulation created using synthesized biologically active lipids showed additive anti-cancer effects and reduced tumorigenic potential.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2024)